2024 Generic Medicine Pharmaceutical Manufacturing 
Express Pharma
MARCH 12, 2025
The FDA has an established office in India overseeing the number of qualified manufacturers supplying generic medicines to the US. In the last decade, there has been increased engagement between Indian pharmaceutical manufacturers and the FDA to address manufacturing and quality operations.
Quality Matters
APRIL 18, 2024
Agency for International Development (USAID) and others, we strengthened 22 national medicines regulatory authorities, supported 23 national control and diagnostic laboratories to meet global standards, and advanced quality production with 36 manufacturers for 50 medical products. These USP documentary standards are recognized in U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 19, 2022
This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. by the end of 2023 and may continue to rise in 2024 to 5%. JP Morgan predicts that the US unemployment rate could rise to 4.3% million as part of the Build Back Better Regional Challenge.
Express Pharma
NOVEMBER 15, 2024
Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4
Express Pharma
JUNE 19, 2025
This transition was marked by strategic investments in regulatory-compliant manufacturing facilities, advanced quality systems, and R&D infrastructure. By 2024, more than 750 Indian facilities were registered with the U.S. In FY 2024–25, India’s pharmaceutical exports exceeded USD 30.3 Source: IBEF, 2024 3.
Putting Patients First Blog
MAY 6, 2025
4 ,5 Millions of Americans rely on medicines that are manufactured outside the United States, particularly from close and longstanding allies such as Ireland, Switzerland, and the United Kingdomcountries whose regulatory frameworks for pharmaceutical manufacturing mirror the high standards enforced domestically.
Expert insights. Personalized for you.
66 
Let's personalize your content